The recent developments in **Molina Healthcare (MOH)** seem to be a mix of both positive and negative facets. Activity among insiders reflects a sense of optimism with purchases totaling millions of dollars by **Mark Lowell Keim**, **Maaurice Hebert**, the President & CEO, and others. Interestingly, this came in the context of the company's reported Q4 2024 and Q1 2025 earnings results that missed several estimates. This was despite growth in full-year earnings amidst Q4's upswing and premium revenue surges leading to an 18% boost to MOH's stock at one point. On the downside, Molina Healthcare's stock also experienced falls due to increasing medical costs and perceived political uncertainties. The stock was notably downgraded by Wells Fargo and Truist. In an encouraging move, the company successfully acquired **ConnectiCare** and was awarded contracts to serve dual eligible populations in **Michigan** and **Idaho**. Their capacity to raise $750M in senior notes at a 6.250% interest rate further solidifies their financial footing. Analyst ratings seem to fluctuate between those bullish on MOH due to its strong fundamentals and others cautious given missed EPS and an element of perceived risk.
Molina Healthcare MOH News Analytics from Fri, 19 Jul 2024 07:00:00 GMT to Sat, 08 Mar 2025 09:10:38 GMT -
Rating 0
- Innovation -3
- Information 7
- Rumor -3
